Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A Dull ASCO And The Usual Sell-Off
A Dull ASCO And The Usual Sell-Off
A Dull ASCO And The Usual Sell-Off
Submitted by
admin
on June 7, 2011 - 7:34pm
Source:
Investopedia
News Tags:
ASCO
Celgene
Bristol-Myers Squibb
Incyte
Exelixis
Novartis
YM BioSciences
Neoprobe
Headline:
A Dull ASCO And The Usual Sell-Off
Do Not Allow Advertisers to Use My Personal information
